Clinical Trial: Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919353) titled 'Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3' on Oct. 30.

Brief Summary: The goal of this clinical trial is to test two implementation strategies (digital strategy vs. care navigator strategy) to promote family cascade screening for familial hypercholesterolemia (FH) in Penn Medicine patients diagnosed with FH ("probands"). The main questions this study aims to answer are: (1) evaluating the effect of the approaches on reach (proportion of probands who have at least one family member who completes screening), number of family members screened, proband engagement with the study, and proband LDL-C levels;...